Dermata Therapeutics
$1.16
10
-$0.05-4.07% Today
Statistics
Day High
1.26
Day Low
1.15
52W High
10.84
52W Low
1.1
Volume
72,883
Avg. Volume
2,091,045
Mkt Cap
1.19M
P/E Ratio
0.16
Dividend Yield
-
Dividend
-
Upcoming
Earnings
20MayExpected
Expected EPS
-0.72
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-24.57MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow DRMA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Aclaris Therapeutics
ACRS
Mkt Cap273M
AnaptysBio
ANAB
Mkt Cap1.02B
Journey Medical
DERM
Mkt Cap213.64M
Sol-Gel Technologies
SLGL
Mkt Cap98.9M
Moderna
MRNA
Mkt Cap10.61B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Pfizer
PFE
Mkt Cap140.15B
Johnson & Johnson
JNJ
Mkt Cap455.04B
About
Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of hyperhidrosis and aesthetic conditions. The company was incorporated in 2014 and is headquartered in San Diego, California.
Show more...
CEO
Mr. Gerald T. Proehl
Employees
8
Country
US
ISIN
US2498455045
Listings
0 Comments
Share your thoughts
FAQ
What is Dermata Therapeutics stock price today?▼
The current price of DRMA is $1.16 USD — it has decreased by -4.07% in the past 24 hours. Watch Dermata Therapeutics stock price performance more closely on the chart.
What is Dermata Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Dermata Therapeutics stocks are traded under the ticker DRMA.
Is Dermata Therapeutics stock price growing?▼
DRMA stock has fallen by -20.5% compared to the previous week, the month change is a -3.27% fall, over the last year Dermata Therapeutics has showed a -88.39% decrease.
What is Dermata Therapeutics market cap?▼
Today Dermata Therapeutics has the market capitalization of 1.19M
When is the next Dermata Therapeutics earnings date?▼
Dermata Therapeutics is going to release the next earnings report on May 20, 2026.
What were Dermata Therapeutics earnings last quarter?▼
DRMA earnings for the last quarter are -0.35 USD per share, whereas the estimation was -1.54 USD resulting in a +77.27% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Dermata Therapeutics revenue for the last year?▼
Dermata Therapeutics revenue for the last year amounts to 0 USD.
What is Dermata Therapeutics net income for the last year?▼
DRMA net income for the last year is -24.57M USD.
How many employees does Dermata Therapeutics have?▼
As of April 01, 2026, the company has 8 employees.
In which sector is Dermata Therapeutics located?▼
Dermata Therapeutics operates in the Health Care sector.
When did Dermata Therapeutics complete a stock split?▼
The last stock split for Dermata Therapeutics was on August 01, 2025 with a ratio of 1:10.
Where is Dermata Therapeutics headquartered?▼
Dermata Therapeutics is headquartered in San Diego, US.